Fundraising FoxNovalis LifeSciences — Full Portfolio
26 tracked investments · listed companies and verified rows first
Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
David Walt(Director)inErnest Orticerio(Executive Officer)Ernest Oriticerio(Executive Officer)Masoud Toloue(Former Chief Executive Officer)in
BoardJohn Connolly(Director)inKeith Crandell(Director)
Board seatMarijn DekkersPaul Meister· per SEC Form D · $6.5M raise · filed Jul 2019
Co-investorsARCH Venture PartnersBain Capital VenturesFoothill VenturesIn-Q-TelKhosla Ventures
Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.
AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US
Jason Kelly(Founder)inReshma Shetty(Founder)inBarry Canton(Founder)inAustin Che(Founder)inTom Knight(Founder)inBartholomew Canton(Executive Officer)
Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+62 more
Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases.
AgTechAI & Machine LearningBiotechDeep TechHealthtechBoston, US
Andrew Calabrese(Scientific Co-Founder)inAndrew Calabrese, Ph.D.(Scientific Co-Founder)Douglas E. Hutchens(CSO)inLogan Andrews(Head of Program Management)inPhilip Austin(Managing Partner, Anterra Capital; co-founder of Animol)inAndrew Plant(Executive Officer, Director)in
Board seatMarijn Dekkers· per SEC Form D
Co-investorsAnterra CapitalDYDX Capital
Activ Surgical develops intraoperative surgical intelligence technology for surgeons, using AR, AI, machine learning, and sensing to display physiological structures and functions not visible to the naked eye.
AI & Machine LearningHealthtechMedical DevicesBoston, US
Peter Kim(Founder)inMichael Ruehlman(Executive Officer)inTodd Usen(Executive Officer, Director)in
BoardEmily Casey(Director)Ashok Krishnamurthi(Director)inDavid Wells(Director)
Board seatPaul Meister· per SEC Form D · $15M raise · filed Jul 2020
Co-investorsReimagined VenturesAlumni VenturesArtis VenturesBasecamp FundCastor VenturesCota Capital+8 more
US agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
AgTechResearch Triangle Park, US
Scott Uknes(Manager)inEric Ward(Manager)Paul Schulze-Lefert(President)Michael Koziel(Vice President and Manager)
BoardThomas Dietz(Manager)Kristina Burow(Manager)in
Board seatMarijn Dekkers· per SEC Form D
Co-investorsAliment CapitalBlue Horizon CorporationPontifax AgTechARCH Venture PartnersBill & Melinda Gates FoundationLeaps by Bayer+1 more
BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs.
BiotechDeep TechMedical DevicesPhiladelphia, US
Peter Keller(Executive Officer, Director)in
BoardElaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)
Board seatPaul Meister· per SEC Form D
Co-investorsAscendo VenturesBaselayer CapitalCardanoGhaf Capital Partnersgumi IncPRIMAL CAPITAL+2 more
Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases.
AgTechAI & Machine LearningBiotechBoston, US
Jacqueline Heard(Executive Officer, Director)inTom Meade(Chief Science Officer)Philip Austin(Director)inSteffen Helmling(Director)Anthony Klemm(CEO and Board Director)
Board seatMarijn Dekkers· per SEC Form D
Co-investorsAlumni VenturesCastor VenturesConnecticut InnovationsDYDX CapitalEndeavor8Germin8 Ventures+5 more
Everest Biolabs develops automated instruments, size-exclusion chromatography columns, and ELISA assays for extracellular vesicle (EV) isolation, concentration, and quantification.
BiotechDeep TechHardwareWaltham, US
George Daaboul(Executive Officer, Director)inDavid Freedman(Executive Officer, Director)
BoardVinit Nijhawan(Director)inDavid Walt(Director)
Board seatPaul Meister· per SEC Form D · $5.7M raise · filed Mar 2026
Co-investorsMassVentures
Flywheel provides a platform for organizing, managing, and sharing medical imaging data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US
Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)inColby Moosman(Executive Officer)inMatthew D. Michela(Executive Officer, Director)inSarah Fazio(Executive Officer)Jim Olson(Executive Officer)in
Board seatMarijn DekkersPaul MeisterDevin Leake· per SEC Form D
Co-investors8VCAlumni VenturesBeringeaGreat North VenturesIntuitive VenturesiSelect Fund+4 more
Early commercial stage company selling a real-time cell analyzer to pharma companies.
BiotechCharlottesville, US
Sean Hart(Executive Officer, Director)inRenee Hart(Executive Officer, Director)Robert Heiser(Director)Pete Buzy(Director)Dennis Walczewski(Director)Paul Meister(Director)
Board seatPaul Meister· per SEC Form D · $9.3M raise · filed Mar 2022
Co-investorsAsahi Kasei Corporate Venture Capital
Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies.
BiotechDigital HealthHealthtechMedical DevicesNatick, US
Paul Blavin(Co-Founder & Vice Chairman)inStanley Lapidus(Director)inDawn Mattoon, PhD(Chief Executive Officer)Joseph Sedlak(Executive Officer, Director)
BoardSonja Hoel Perkins(Director)in
Board seatPaul Meister· per SEC Form D
Co-investorsAvestria VenturesHatteras Venture PartnersiSelect FundMindshift CapitalPortfoliaSozo Ventures+2 more
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in
Board seatMarijn Dekkers· per SEC Form D · $37M raise · filed Apr 2021
Co-investorsARCH Venture PartnersM VenturesNorthpond VenturesIllumina Ventures
Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.
BiotechDeep TechMedical DevicesNiel, BE
Co-investorsFund+PMVBoehringer Ingelheim Venture FundEQT Life SciencesOmega FundsPWV
Flywheel provides a building operations platform for facility and property managers to manage maintenance teams, track preventative and ad hoc tasks, and analyze energy usage.
CleantechEnergyPropTechSaaSDallas, US
Steve Gossett, Jr.(CEO)Brian BezdekBrian Ratcliff
Co-investors8VCBraemar Energy VenturesNVIDIA
WP Engine (Flywheel) provides enterprise-grade WordPress hosting infrastructure designed to support high-traffic websites with advanced caching, security, and network optimization.
Cloud ComputingDeveloper ToolsSaaSAustin, US
Jason Cohen(Founder)
Co-investorsFive Elms CapitalHyde Park Venture PartnersNelnet8VCCratonLightbank+2 more
LevitasBio develops label-free cell isolation and analysis technology for life science researchers, enabling higher-quality cell sample preparation without introducing bias or gene expression modifications.
BiotechDeep TechHardwareMedical Devices
Dr. Gozde Durmus(Co-founder)Dr. Utkan Demirci(Co-founder)Dr. Lars Steinmetz(Co-founder)Martin PieprzykinSuzanne Weaverin
Co-investorsDecheng CapitalStartX
Ori develops expandable-unit technology for multifamily real estate, enabling hotel-to-housing conversions and ground-up developments that increase unit density while maintaining livability.
Construction TechHardwareImpact & Social GoodPropTech
Hasier Larrea(Founder)
Co-investorsIngka InvestmentsPresidio VenturesThe E14 FundAmadeus Capital PartnersDelin VenturesEpisode1+4 more
ORI provides an integrated business planning platform for supply chain professionals, combining demand planning, S&OP, S&OE, data analytics, and long-term planning in one tool.
AI & Machine LearningLogistics & Supply ChainSaaS
Brant Slade(Founder)in
Co-investorsKickstartAmadeus Capital PartnersDelin VenturesKhosla VenturesNorthpond VenturesOctopus Ventures+2 more
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical Devices
Co-investorsAmadeus Capital PartnersKindred CapitalOctopus VenturesDelin VenturesNorthpond VenturesPuhua Capital
Orogen Therapeutics uses AI and machine learning to accelerate drug discovery, focusing on small molecule candidates for immuno-inflammatory diseases.
AI & Machine LearningBiotechDeep TechMedical Devices
Mark Pykett(Chief Executive Officer)
HealthtechCambridge, US
Rahul Dhanda(Executive Officer, Director)inJames Collins(Director)David Walt(Director)in
BoardIssi Rozen(Director)in
Co-investorsCatalio Capital Management, LPIllumina VenturesCatalio Capital ManagementGood VenturesGV (Google Ventures)Northpond Ventures
SkylineDx develops gene-based diagnostic tests that identify how patients will respond to treatment by analyzing genomic alterations in disease cells, serving oncology and dermatology care providers and patients.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Diego, US
Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices.
AI & Machine LearningBiotechDeep TechHardwareHealthtechSan Diego, US
Daniel G. Gibson(Executive Officer)inTodd R. Nelson(Executive Officer, Director)Eric Esser(Executive Officer)inWilliam F. Snider(Director)Andrea L. Jackson(Director)inChristine A. Tsingos(Director)
Co-investorsNorthpond Ventures
BiotechDigital HealthHealthtechMedical DevicesMiami, US
Matthew H. J. Kim(Executive Officer, Director)
BoardTimothy Barabe(Director)Eric Stone(Director)Jonathan T. Lord(Director)Jeffrey Goodman(Director)
Co-investorsFlorida Technology Seed Capital Fund
AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.
AI & Machine LearningBiotechDeep TechHealthtechStanford, US
Thorsten Stafforst(Chairman of the Board of Directors)inKris ElveruminTodd Bazemore(Chief Executive Officer)inJin (Billy) Li(Treasurer and Secretary)inPaul Vogel(Chief Executive Officer and President)in
BoardRodger Novak(Chair)in
Co-investors+ND CapitalARCH Venture PartnersForbionVenrockFast Track InitiativeLifelink+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.